Role of Maiden Pharma cough syrups in Gambia kids' deaths not confirmed

Indian Health ministry sources say the Haryana-based drug maker is currently being probed for lapses in good manufacturing practices

The issue of the cough syrup made by India’s Maiden Pharmaceuticals has taken a new turn, with Gambia saying it has not yet confirmed that the cough syrup caused the death of 70 children from acute kidney injury.

Health ministry sources indicated that India is currently investigating the Haryana-based drug maker for lapses in good manufacturing practices. The regulator here also stopped production at its Sonipat site last month. “We have nothing to update as of now, the investigation is ongoing,” the official said.

According to a Reuters report from Gambia, a representative of the country’s Medicines Control Agency said